News & Perspective

Dec 16, 2016

Dec 16, 2016

News Scan for Dec 16, 2016

New Zika cases
H7N2 avian flu in NYC cats
Ricin exposure
Immune globulin for anthrax
Cholera in Yemen

Sep 18, 2015

Sep 18, 2015

News Scan for Sep 18, 2015

Ebola drug expedited
Polio vaccine regimen tested
Another US biolab breach
H1N1 genetic risk
Danish MRSA dynamics

Jun 19, 2015

Jun 19, 2015

News Scan for Jun 19, 2015

B anthracis kill failure
Ebola drug disappoints
Salmonella from geckos
Diagnosing Zika virus
Dengue in Yemen

Jun 05, 2015

Jun 05, 2015

News Scan for Jun 05, 2015

Five Saudi MERS cases
NIH pharmacy lapses
Drug-resistant Shigella
Zika virus in Americas
Call for better lab biosecurity

Jun 01, 2015

Jun 01, 2015

News Scan for Jun 01, 2015

Ebola in Sierra Leone
DoD anthrax probe
Chikungunya cases
Avian flu in Taiwan

Jul 24, 2014

Jul 24, 2014

News Scan for Jul 24, 2014

CDC lab biosafety update
GM mosquitoes to fight dengue
GSK's malaria vaccine
Cholera vaccination in Haiti
Global hepatitis progress

Jul 14, 2014

Jul 14, 2014

News Scan for Jul 14, 2014

CDC handling of anthrax agent
More West Africa Ebola
Moral debt for Haiti cholera
Tattoo product recall

Jul 10, 2014

Jul 10, 2014

News Scan for Jul 10, 2014

Questions on anthrax scare
Ebola in Liberian health workers
Office for climate and health

Oct 18, 2012

Oct 18, 2012

HHS seeks comments on risks of H5N1 research

(CIDRAP News) – Federal health officials are inviting the public to weigh in on whether research on H5N1 avian influenza viruses, including strains modified in the lab to make them more transmissible, is risky enough to require new safety regulations and precautions.

Pages

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»